Literature DB >> 15195533

[New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects].

M Romero Gómez1, J D Bautista, L Grande, R M Ramos Guerrero, D Sánchez Muñoz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195533

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


× No keyword cloud information.
  5 in total

1.  Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis.

Authors:  Manuel Romero-Gomez; Maria Jover; Daniel Diaz-Gomez; Laura-Collantes de Teran; Regina Rodrigo; Ines Camacho; Miriam Echevarria; Vicente Felipo; Juan-D Bautista
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 2.  Hyperammonemia and lactic acidosis in adults: Differential diagnoses with a focus on inborn errors of metabolism.

Authors:  Michel Tchan
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

Review 3.  Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy.

Authors:  Manuel Romero-Gómez
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

Review 4.  Gut ammonia production and its modulation.

Authors:  Manuel Romero-Gómez; María Jover; J Jorge Galán; A Ruiz
Journal:  Metab Brain Dis       Date:  2008-12-10       Impact factor: 3.584

5.  THDP17 decreases ammonia production through glutaminase inhibition. A new drug for hepatic encephalopathy therapy.

Authors:  M Mar Díaz-Herrero; José A del Campo; Pilar Carbonero-Aguilar; José M Vega-Pérez; Fernando Iglesias-Guerra; Ignacio Periñán; Francisco J Miñano; Juan Bautista; Manuel Romero-Gómez
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.